APA

Ramagopalan S. V., Dyment D. A., Morrison K. M., Herrera B. M., Deluca G. C., Lincoln M. R., Orton S. M., Handunnetthi L., Chao M. J., Sadovnick A. D. & Ebers G. C. (20080718). Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis. : BMC medical genetics.

Chicago

Ramagopalan Sreeram V, Dyment David A, Morrison Katie M, Herrera Blanca M, Deluca Gabriele C, Lincoln Matthew R, Orton Sarah M, Handunnetthi Lahiru, Chao Michael J, Sadovnick A Dessa and Ebers George C. 20080718. Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis. : BMC medical genetics.

Harvard

Ramagopalan S. V., Dyment D. A., Morrison K. M., Herrera B. M., Deluca G. C., Lincoln M. R., Orton S. M., Handunnetthi L., Chao M. J., Sadovnick A. D. and Ebers G. C. (20080718). Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis. : BMC medical genetics.

MLA

Ramagopalan Sreeram V, Dyment David A, Morrison Katie M, Herrera Blanca M, Deluca Gabriele C, Lincoln Matthew R, Orton Sarah M, Handunnetthi Lahiru, Chao Michael J, Sadovnick A Dessa and Ebers George C. Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis. : BMC medical genetics. 20080718.